Your browser doesn't support javascript.
loading
Testosterona inhibe la actividad de la aldosterona sintasa silvestre y quimérica in vitro / Testosterone inhibits human wild-type and chimeric aldosterone synthase activity in vitro
Vecchiola, Andrea; Fuentes, Cristóbal A; Carvajal, Cristian A; Campino, Carmen; Allende, Fidel; Tapia-Castillo, Alejandra; Lagos, Carlos F; Fardella, Carlos E.
Afiliación
  • Vecchiola, Andrea; Pontificia Universidad Católica de Chile. Facultad de Medicina. Departamento de Endocrinología. Santiago. CL
  • Fuentes, Cristóbal A; Pontificia Universidad Católica de Chile. Facultad de Medicina. Departamento de Endocrinología. Santiago. CL
  • Carvajal, Cristian A; Pontificia Universidad Católica de Chile. Facultad de Medicina. Departamento de Endocrinología. Santiago. CL
  • Campino, Carmen; Pontificia Universidad Católica de Chile. Facultad de Medicina. Departamento de Endocrinología. Santiago. CL
  • Allende, Fidel; Centro Traslacional de Endocrinología UC (CETREN). Santiago. CL
  • Tapia-Castillo, Alejandra; Pontificia Universidad Católica de Chile. Facultad de Medicina. Departamento de Endocrinología. Santiago. CL
  • Lagos, Carlos F; Universidad San Sebastián. Facultad de Medicina y Ciencia. Santiago. CL
  • Fardella, Carlos E; Pontificia Universidad Católica de Chile. Facultad de Medicina. Departamento de Endocrinología. Santiago. CL
Rev. méd. Chile ; 149(11): 1539-1543, nov. 2021. ilus
Article en Es | LILACS | ID: biblio-1389387
Biblioteca responsable: CL126.2
ABSTRACT

BACKGROUND:

Familial hyperaldosteronism type I is caused by the generation of a chimeric aldosterone synthase enzyme (ASCE) which is regulated by ACTH instead of angiotensin II. We have reported that in vitro, the wild-type (ASWT) and chimeric aldosterone synthase (ASCE) enzymes are inhibited by progesterone and estradiol does not affect their activity.

AIM:

To explore the direct action of testosterone on ASWT and ASCE enzymes. Material and

Methods:

HEK-293 cells were transiently transfected with vectors containing the full ASWT or ASCE cDNAs. The effect of testosterone on AS enzyme activities was evaluated incubating HEK-cells transfected with enzyme vectors and adding deoxycorticosterone (DOC) alone or DOC plus increasing doses of testosterone. Aldosterone production was measured by HPLC-MS/MS. Docking of testosterone within the active sites of both enzymes was performed by modelling in silico.

Results:

In this system, testosterone inhibited ASWT (90% inhibition at five pM, 50% inhibitory concentration (IC50) =1.690 pM) with higher efficacy andpotency than ASCE (80% inhibition at five pM, IC50=3.176 pM). Molecular modelling studies showed different orientation of testosterone in ASWT and ASCE crystal structures.

CONCLUSIONS:

The inhibitory effect of testosterone on ASWT or ASCE enzymes is a novel non-genomic testosterone action, suggesting that further clinical studies are needed to assess the role of testosterone in the screening and diagnosis of primary aldosteronism.
Asunto(s)
Palabras clave

Texto completo: 1 Índice: LILACS Asunto principal: Citocromo P-450 CYP11B2 / Aldosterona Límite: Humans Idioma: Es Revista: Rev. méd. Chile Asunto de la revista: MEDICINA Año: 2021 Tipo del documento: Article

Texto completo: 1 Índice: LILACS Asunto principal: Citocromo P-450 CYP11B2 / Aldosterona Límite: Humans Idioma: Es Revista: Rev. méd. Chile Asunto de la revista: MEDICINA Año: 2021 Tipo del documento: Article